Natural Capsules Ltd
P&F Pattern: Monthly Basis
Morning Star: Monthly Basis
*With Upside, Trail SL*
*Book Profit as per Risk Appetite*
Snapshot
Estab. in ‘93, Mfgs. Hard Gelatin /Cellulose Capsule shells (Printed/Unprinted), Pharma Dosage Forms (Pharma/Neutraceutical).
2 Units: Bengaluru/ Puducherry (Total capacity: 16 Bn capsules p.a.) Capex for increasing up to 24 Bn p.a.
Exports >20 Countries. For FY22 contributed 19% of Sales.
~15% of Clients engaged >10 years.
~2-3% of Sales in R& yrly.
Growing Sales & Profitability: Qtrly / yearly Basis.
Growing TNW. Sound Leverage. Improving WC Cycle.
Sharp Improvement in RoA/RoCE/RoE (in Double Digits) for FY22 vs. FY21
CF from Ops +ve.
Concern:
Moderation in liquidity position as well as capital structure.
Low C&CE of Rs.4 Crs (Jun’22)
*Do Your Own Research as Well. This is Just an Opinion.*
Happy Investing :)
P&F Pattern: Monthly Basis
Morning Star: Monthly Basis
*With Upside, Trail SL*
*Book Profit as per Risk Appetite*
Snapshot
Estab. in ‘93, Mfgs. Hard Gelatin /Cellulose Capsule shells (Printed/Unprinted), Pharma Dosage Forms (Pharma/Neutraceutical).
2 Units: Bengaluru/ Puducherry (Total capacity: 16 Bn capsules p.a.) Capex for increasing up to 24 Bn p.a.
Exports >20 Countries. For FY22 contributed 19% of Sales.
~15% of Clients engaged >10 years.
~2-3% of Sales in R& yrly.
Growing Sales & Profitability: Qtrly / yearly Basis.
Growing TNW. Sound Leverage. Improving WC Cycle.
Sharp Improvement in RoA/RoCE/RoE (in Double Digits) for FY22 vs. FY21
CF from Ops +ve.
Concern:
Moderation in liquidity position as well as capital structure.
Low C&CE of Rs.4 Crs (Jun’22)
*Do Your Own Research as Well. This is Just an Opinion.*
Happy Investing :)